英文简介
Dr. Zhou is a Professor, Principal Investigator, and Doctoral Supervisor at Shandong First Medical University. He currently serves as Deputy Director of the Affiliated Eye Institute, Executive Deputy Director of the State-Province Jointly Established Key Laboratory Cultivation Base and Shandong Provincial Key Laboratory of Ophthalmology, and Vice Dean of the Affiliated Qingdao Eye Hospital.

As Principal Investigator, he has led 7 NSFC projects, including the Joint Key Project, General Program, and Young Scientists Fund, as well as 5 additional projects supported by the National Key R&D Program of China and the Shandong Provincial Fund for Distinguished Young Scholars. He is a recipient of the National Science Fund for Distinguished Young Scholars, a National Youth Top-notch Talent (Ten Thousand Talents Program) of the Organization Department of the CPC Central Committee, and a Distinguished Taishan Scholar as well as a Young Taishan Scholar of Shandong Province. He has published over 180 papers with more than 3,700 citations. In the past five years, as first or corresponding author, he has published 15 CAS Q1 papers in high-impact journals including Progress in Retinal and Eye Research (2026, IF 14.7), Cell Reports Medicine (2026, IF 10.6), Nature Communications (2025, IF 15.7), NPJ Digital Medicine (2025, IF 15.1), ACS Nano (2023, IF 15.8), and Journal of Clinical Investigation (2022, IF 19.4). His honors include one Second Prize of the National Technological Invention Award (as the 3rd awardee, currently under public announcement), two Second Prizes of the National Science and Technology Progress Award (as the 3rd and 7th awardee, respectively), and four First Prizes (including both Science and Technology Progress Award and Technological Invention Award) from Shandong Province, in three of which he ranked 2nd.

With 20 years of research experience in corneal repair, regeneration, and functional reconstruction, he has systematically addressed key challenges in tissue-engineered corneal construction and transplantation, and developed a series of innovative technologies and products for functional corneal reconstruction, securing three Class III medical device registration certificates in China.